Melguizo Alonso, Consolación Author
Multidrug resistance and rhabdomyosarcoma (review)
- Melguizo C.
- Prados J.
- Rama A.R.
- Ortiz R.
- Álvarez P.J.
- Fernández J.E.
- Aranega A.
Oncology Reports - 1/10/2011
- JCR Quartile: Q4 (2011)
- SJR Quartile: Q1
- JCR Impact Factor: 1.835 (2011)
- Category normalized Impact: 0.209 (2011)
- CiteScore: 6.9 (2020)
- SJR: 0.882 (2011
- SNIP: 0.681 (2011
- JCR 5-year Impact Factor: 1.827
- JCR Categories: ONCOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Oncology (Q2); Cancer Research (Q3)
- Scopus
- ORCID
- Web of Science
Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review
- Doello K.
- Ortiz R.
- Alvarez P.
- Melguizo C.
- Cabeza L.
- Prados J.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL - 19/5/2018
- SJR Quartile: Q2
- JCR Impact Factor: 2.029 (2018)
- CiteScore: 4.1 (2020)
- SJR: 0.736 (2018
- SNIP: 0.672 (2018
- JCR 5-year Impact Factor: 2.456
- JCR Categories: NUTRITION & DIETETICS
- SJR Categories: Medicine (miscellaneous) (Q2); Nutrition and Dietetics (Q2); Cancer Research (Q3); Oncology (Q3)
- Scopus
- ORCID
- Web of Science
Antitumor Effect of the Ethanolic Extract from Seeds of Euphorbia lathyris in Colorectal Cancer
- Cristina Mesas
- Rosario Martínez
- Raúl Ortíz
- Milagros Galisteo
- María López-Jurado
- Laura Cabeza
- Gloria Perazzoli
- Consolación Melguizo Alonso
- Jesus Maria Porres Foulquie
- Jose Prados
Nutrients - 9/02/2021
- JCR Impact Factor: 6.706 (2021)
- JCR 5-year Impact Factor: 7.185
- JCR Categories: NUTRITION & DIETETICS
- Scopus
- ORCID
- Web of Science
Serum NMR metabolomics analysis of human metastatic colorectal cancer: biomarkers and pathway analysis
- Ana Isabel Tristán
- Encarnación González‐Flores
- Ana del Mar Salmerón
- Ana Cristina Abreu
- Octavio Caba
- Cristina Jiménez‐Luna
- Consolación Melguizo
- José Prados
- Ignacio Fernández
NMR in Biomedicine - 22/03/2023
- CiteScore: 7.1 (2022)
- SJR: 1.069 (2022
- SNIP: 1.052 (2022
- Scopus
- ORCID
- Web of Science
Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells
- Melguizo, C
- Prados, J
- Marchal, JA
- Velez, C
- Carrillo, E
- Boulaiz, H
- Sanchez-Montesinos, I
- Madeddu, R
- Aranega, A
Neoplasma - 1/1/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q3
- JCR Impact Factor: 0.782 (2022)
- Category normalized Impact: 0.101 (2003)
- CiteScore: 3.3 (2020)
- SJR: 0.339 (2003
- SNIP: 0.43 (2003
- SJR Categories: Cancer Research (Q3)
- Scopus
- ORCID
- Web of Science
Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase
- Prados, J
- Melguizo, C
- Fernandez, JE
- Carrillo, E
- Marchal, JA
- Boulaiz, H
- Martinez, A
- Rodriguez-Serrano, F
- Aranega, A
Neoplasma - 1/1/2006
- JCR Quartile: Q4 (2006)
- SJR Quartile: Q3
- JCR Impact Factor: 1.247 (2022)
- Category normalized Impact: 0.07 (2006)
- CiteScore: 3.3 (2020)
- SJR: 0.483 (2006
- SNIP: 0.632 (2006
- SJR Categories: Cancer Research (Q3)
- Scopus
- ORCID
- Web of Science
Paclitaxel-loaded hollow-poly(4-vinylpyridine) nanoparticles enhance drug chemotherapeutic efficacy in lung and breast cancer cell lines
- Contreras-Caceres, Rafael
- Leiva, Maria C.
- Ortiz, Raul
- Diaz, Amelia
- Perazzoli, Gloria
- Casado-Rodriguez, Miguel A.
- Melguizo, Consolacion
- Baeyens, Jose M.
- Lopez-Romero, Juan M.
- Prados, Jose
Nano Research - 1/03/2017
- JCR Quartile: Q1 (2017)
- SJR Quartile: Q1
- JCR Impact Factor: 7.994 (2022)
- Category normalized Impact: 0.635 (2017)
- CiteScore: 14.4 (2020)
- SJR: 3.064 (2017
- SNIP: 1.4 (2017
- JCR 5-year Impact Factor: 8.045
- JCR Categories: PHYSICS, APPLIED
- SJR Categories: Electrical and Electronic Engineering (Q1); Materials Science (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1)
- Scopus
- ORCID
- Web of Science
Lipid-based nanoparticles: Application and recent advances in cancer treatment
- García-Pinel B.
- Porras-Alcalá C.
- Ortega-Rodríguez A.
- Sarabia F.
- Prados J.
- Melguizo C.
- López-Romero J.M.
Nanomaterials - 1/4/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.324 (2019)
- JCR 5-year Impact Factor: 4.514
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Chemical Engineering (miscellaneous) (Q1); Materials Science (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
Electrospun nanofibers: Recent applications in drug delivery and cancer therapy
- Contreras-Cáceres R.
- Cabeza L.
- Perazzoli G.
- Díaz A.
- López-Romero J.
- Melguizo C.
- Prados J.
Nanomaterials - 1/4/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.324 (2019)
- CiteScore: 4.21 (2018)
- SJR: 0.896 (2018
- SNIP: 1.112 (2018
- JCR 5-year Impact Factor: 4.514
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Chemical Engineering (miscellaneous) (Q1); Materials Science (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review
- Gloria Perazzoli
- Olga M. García-Valdeavero
- Mercedes Peña-Contreras
- Jose Prados
- Consolación Melguizo Alonso
- Cristina Jiménez Luna
Metabolites - 1/07/2023
- Scopus
- ORCID
- Web of Science
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador